Latest news
16.04.2018
DEINOVE and GREENTECH announce the launch of HEBELYS®, the first cosmetic active ingredient resulting from their collaboration
HEBELYS ® is a natural active ingredient produced by the fermentation of Sphingomonas , a bacterium belonging to the DEINOVE proprietary...
13.04.2018
DEINOVE takes on a whole new dimension with the acquisition of MORPHOCHEM’s clinical-stage antibiotic compound
MORPHOCHEM's MCB3837 antibiotic compound aims to treat severe gastrointestinal infections caused by Clostridium difficile , a priority...
Events
21.04.2018 to 24.04.2018
ECCMID 2018 | Madrid, Spain
28th European Congress of Clinical Microbiology and Infectious Disease More
26.04.2018
R&D DAY : la strategie Antibiotiques de DEINOVE
DEINOVE détaillera sa stratégie de développement dans les Antibiotiques Le jeudi 26 avril 2018 à 10h00 SOCIÉTÉ FRANÇAISE DES ANALYSTES...